Compound Detail
CHEMBL317052
REGADENOSON ANHYDROUS 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1
Basic Information
| ChEMBL ID | CHEMBL317052 |
| Name | REGADENOSON ANHYDROUS |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LZPZPHGJDAGEJZ-AKAIJSEGSA-N |
| Therapeutic | ✓ Yes |
5
Targets
11
Activities
2
Assay Types
0
PK Parameters
20
Publications
1
Known Names
4
Indications
Molecular Properties
390.4
MW (Da)
-2.43
ALogP
12
HBA
5
HBD
186.5
PSA (Ų)
0.32
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2008 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Coronary Disease Anemia, Sickle Cell Retinal Artery Occlusion Myocardial Ischemia
Activity Summary
Ki 10 meas. best 6.54
EC50 1 meas. best 5.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosine receptor A2a CHEMBL251 | Ki | 6.54 | 6.42 | 290.0 | 5 |
| Adenosine receptor A2a CHEMBL302 | Ki | 6.54 | 6.54 | 290.0 | 1 |
| Adenosine receptor A1 CHEMBL226 | Ki | 5.42 | 5.42 | 3770.0 | 1 |
| Adenosine receptor A2b CHEMBL255 | EC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | Ki | 5.0 | 5.0 | 10000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine